Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO 510(k) Report May Recommend Splitting Up Class II, Industry Predicts

This article was originally published in The Gray Sheet

Executive Summary

Some device industry veterans predict the pending government report on FDA's 510(k) process will include criticisms of the program and may recommend subdividing Class II moderate-risk devices into two or more new categories
Advertisement

Related Content

GAO Drafts 510(k) Report; Talk Grows Of Pre-Market Reform Legislation In ’09
GAO Drafts 510(k) Report; Talk Grows Of Pre-Market Reform Legislation In ’09
Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar
Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar
510(k) Reform Debate Resurfaces As GAO Completes Mandated Report
510(k) Reform Debate Resurfaces As GAO Completes Mandated Report
Advertisement
UsernamePublicRestriction

Register

MT026614

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel